Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
75.5M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
12.5M
-
Shares change
-
-2.78M
-
Total reported value, excl. options
-
$14.9M
-
Value change
-
-$4.69M
-
Number of buys
-
25
-
Number of sells
-
-14
-
Price
-
$1.19
Significant Holders of Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) as of Q2 2021
51 filings reported holding CLRB - Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share as of Q2 2021.
Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.5M shares
of 75.5M outstanding shares and own 16.54% of the company stock.
Largest 10 shareholders include Consonance Capital Management LP (3.91M shares), VANGUARD GROUP INC (1.87M shares), RENAISSANCE TECHNOLOGIES LLC (1.01M shares), BOXER CAPITAL, LLC (920K shares), BlackRock Inc. (716K shares), Maven Securities LTD (650K shares), SABBY MANAGEMENT, LLC (427K shares), GEODE CAPITAL MANAGEMENT, LLC (397K shares), TWO SIGMA ADVISERS, LP (351K shares), and GSA CAPITAL PARTNERS LLP (298K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.